U.S. Medical Equipment Stock News

NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Is Dave (DAVE) Cheap As Raised 2026 Outlook And Buyback Refocus Valuation?

Dave (DAVE) moved back into focus after its early August earnings update, which paired higher reported revenue with a dip in quarterly net income, a raised 2026 revenue outlook, and completion of a sizable buyback. See our latest analysis for Dave. The Q2 update and raised 2026 revenue outlook came alongside a sharp reset in Dave’s share price. The stock is down 12.96% on a 1 day basis and 20.67% over 30 days, yet still carries a 44.86% year to date share price return and a 1 year total...
NYSE:GEF
NYSE:GEFPackaging

Should Greif’s Higher Q3 Earnings and Polymer Bolt‑On Focus Prompt Action From GEF Investors?

In the third quarter of 2026, Greif, Inc. reported higher sales of US$1,165.6 million and net income of US$77.8 million, while updating that one long-running repurchase program dating back to 2005 has now reached 5,674,369 shares for US$360.48 million and a newer 2026 authorization saw no buybacks in the latest quarter. Management also confirmed on the recent earnings call that Greif is prioritizing organic growth supported by recurring bolt-on acquisitions in advanced polymer packaging,...
NasdaqGS:JOUT
NasdaqGS:JOUTLeisure

Johnson Outdoors (JOUT) Stock Gains Little As Tariff Refund Fuels Profit

Johnson Outdoors came into this earnings print as an unprofitable outdoor gear stock that had quietly climbed about 9% over the past month. The market’s first take was calm, with the stock up only 1.4% to US$48.22 after the release. The headline is in the income statement. Q3 basic earnings per share jumped to US$1.44 on revenue of US$189.7m, powered by a large tariff refund that lifted margins and turned what has been a loss making twelve months into a sharply profitable quarter. Impressed...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Pool (POOL) Could Be 19% Undervalued As Dividend Puts Valuation Back In Focus

Dividend declaration puts Pool stock back in focus Pool (POOL) has resurfaced on investor radars after its Board of Directors declared a quarterly cash dividend of $1.30 per share, payable on August 27, 2026 to holders of record on August 13. See our latest analysis for Pool. Pool's latest dividend decision comes after a mixed share price pattern, with a 7 day share price return of 11.09% and a 90 day share price return of 11.66%, set against a year to date share price decline of 10.19% and a...
NYSE:EPC
NYSE:EPCPersonal Products

How Weaker Profitability And Cut Guidance At Edgewell Personal Care (EPC) Has Changed Its Investment Story

In early August 2026, Edgewell Personal Care reported third-quarter 2026 results showing sales of US$570.1 million but a sharp drop in net income to US$13.7 million, cut its full-year 2026 GAAP EPS and net sales outlook, and confirmed a quarterly US$0.15 dividend while leaving about US$85 million of its 2025 buyback authorization unused. These results highlight that, despite modest revenue growth and ongoing cash returns via dividends and potential repurchases, profitability pressures and a...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Camtek (NasdaqGM:CAMT) Stock Looks Rich On Earnings But Strong On Returns

Camtek stock has delivered very strong gains over the past few years, yet its valuation checks now lean expensive. This raises a clear question about how much upside is left in the current price. Camtek has returned 320.3% over the last 5 years, which puts a lot of optimism into the share price that newer investors need to weigh carefully. Expectations for continued growth in semiconductor inspection demand can support the current valuation. However, any slowdown in orders or pressure on...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Precigen (PGEN) Could Be 50% Undervalued On Strong Earnings Turnaround

Why Precigen’s latest earnings drew investor attention Precigen (PGEN) has drawn fresh interest after its 4 August 2026 earnings release, which showed second quarter revenue of US$54.98 million and net income of US$20.07 million, compared with losses in the prior year period. See our latest analysis for Precigen. Since those results on 4 August 2026, Precigen’s recent earnings swing to profit has coincided with strong momentum, with a 30 day share price return of 35.9% and a 1 year total...